A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
Mayo Clinic
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Ono Pharmaceutical Co. Ltd
Indiana University
Children's Hospital of Philadelphia
Vittoria Biotherapeutics
Mayo Clinic
SciTech Development, Inc.
University of Alabama at Birmingham
Ono Pharmaceutical Co. Ltd
GC Cell Corporation
Therapeutic Advances in Childhood Leukemia Consortium
Aurigene Discovery Technologies Limited